Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer
Condition: Advanced Liver Cancer Interventions: Drug: PD-1; Drug: Sorafenib Sponsor: Guangxi Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials